JWCA
MRNA icon

J.W. Cole Advisors’s Moderna MRNA Stock Holding History

J.W. Cole Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,261
Closed -$269K – 953
2024
Q2 		$269K Buy
2,261
+34
+2% +$4.3K 0.01% 745
2024
Q1 		$237K Buy
2,227
+5
+0.2% +$504 0.01% 776
2023
Q4 		$221K Buy
2,222
+174
+8% +$14.6K 0.01% 731
2023
Q3 		$212K Sell
2,048
-77
-4% -$8.59K 0.02% 668
2023
Q2 		$258K Sell
2,125
-346
-14% -$46.2K 0.02% 624
2023
Q1 		$379K Buy
2,471
+145
+6% +$23.9K 0.03% 521
2022
Q4 		$418K Sell
2,326
-127
-5% -$20.8K 0.03% 462
2022
Q3 		$290K Sell
2,453
-858
-26% -$130K 0.02% 550
2022
Q2 		$473K Sell
3,311
-1,453
-30% -$208K 0.04% 420
2022
Q1 		$821K Buy
4,764
+1,230
+35% +$207K 0.06% 325
2021
Q4 		$898K Sell
3,534
-2,353
-40% -$688K 0.06% 320
2021
Q3 		$2.27M Buy
5,887
+532
+10% +$196K 0.16% 91
2021
Q2 		$1.26M Sell
5,355
-355
-6% -$63.4K 0.1% 233
2021
Q1 		$748K Buy
5,710
+3,741
+190% +$542K 0.07% 297
2020
Q4 		$206K Sell
1,969
-1,462
-43% -$148K 0.02% 588
2020
Q3 		$243K Buy
+3,431
New +$239K 0.02% 609

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

J.W. Cole Advisors's MRNA Position: Q3 2024 in Review

J.W. Cole Advisors sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,261 shares — an estimated $269K sold.

J.W. Cole Advisors first reported a position in MRNA in Q3 2020 and held it in 16 quarters. The position peaked at $2.27M in Q3 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • J.W. Cole Advisors reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • J.W. Cole Advisors sold 2,261 Moderna shares in Q3 2024, an estimated $269K.
  • J.W. Cole Advisors first reported a position in Moderna in Q3 2020 and held it in 16 quarters.
  • J.W. Cole Advisors's Moderna position peaked at $2.27M in Q3 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on J.W. Cole Advisors's 13F filing for Q3 2024, filed 24 Oct 2024.